Contracts
You have no credits left. To view this article subscribe to Business News.
You have used {{points}} and have {{current_points}} remaining. Your credits will reset on {{reset_date}}.
This article is part of a special report and is available to paid Business News subscribers only.
You can purchase access to this special report or subscribe to Business News.
You can purchase access to this special report or subscribe to Business News.
This article is premium content and is available to paid Business News subscribers only.
Subscribe to Business News.
Subscribe to Business News.
Tuesday, 29 April, 2003 - 22:00
Solbec Pharmaceuticals Ltd
28/4/03
Has secured funding from the Federal Government's Biotechnology Innovation Fund to develop research on its anti-cancer drug SBP002. The BiotechnologyInnovation Fund will fund half the $393,768 project. Trial results are expected in September 2004.
Above information supplied by: email:
spiwatch1@optusnet.com.au